Irisin, the metabolic syndrome and follistatin in humans
Tóm tắt
Từ khóa
Tài liệu tham khảo
Boström, P. et al. A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 481, 463–468 (2012).
Park, K. H. et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J. Clin. Endocrinol. Metab. http://dx.doi.org/10.1210/jc.2013-2373 .
Vamvini, M. T. et al. Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans. Eur. J. Endocrinol. 169, 829–834 (2013).
Zhang, H. J. et al. Irisin is inversely associated with intrahepatic triglyceride contents in obese adults. J. Hepatol. 59, 557–562 (2013).
Raschke, S. et al. Evidence against a beneficial effect of irisin in humans. PLoS ONE 8, e73680 (2013).
Erickson, H. P. Irisin and FNDC5 in retrospect: an exercise hormone or a transmembrane receptor? Adipocyte 2, 289–293 (2013).
Huh, J. Y. et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61, 1725–1738 (2012).
Ivanov, I. P., Firth, A. E., Michel, A. M., Atkins, J. F. & Baranov, P. V. Identification of evolutionarily conserved non-AUG-initiated N-terminal extensions in human coding sequences. Nucleic Acids Res. 39, 4220–4234 (2011).